These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 27126786)
1. Glycan characterization of biopharmaceuticals: Updates and perspectives. Planinc A; Bones J; Dejaegher B; Van Antwerpen P; Delporte C Anal Chim Acta; 2016 May; 921():13-27. PubMed ID: 27126786 [TBL] [Abstract][Full Text] [Related]
2. Glycosylation of biosimilars: Recent advances in analytical characterization and clinical implications. Duivelshof BL; Jiskoot W; Beck A; Veuthey JL; Guillarme D; D'Atri V Anal Chim Acta; 2019 Dec; 1089():1-18. PubMed ID: 31627805 [TBL] [Abstract][Full Text] [Related]
3. Versatile characterization of glycosylation modification in CTLA4-Ig fusion proteins by liquid chromatography-mass spectrometry. Zhu L; Guo Q; Guo H; Liu T; Zheng Y; Gu P; Chen X; Wang H; Hou S; Guo Y MAbs; 2014; 6(6):1474-85. PubMed ID: 25484062 [TBL] [Abstract][Full Text] [Related]
4. N-glycan Analysis in Molecular Medicine: Innovator and Biosimilar Protein Therapeutics. Borza B; Hajba L; Guttman A Curr Mol Med; 2020; 20(10):828-839. PubMed ID: 33272172 [TBL] [Abstract][Full Text] [Related]
5. Physicochemical Characterization, Glycosylation Pattern and Biosimilarity Assessment of the Fusion Protein Etanercept. Montacir O; Montacir H; Springer A; Hinderlich S; Mahboudi F; Saadati A; Parr MK Protein J; 2018 Apr; 37(2):164-179. PubMed ID: 29411222 [TBL] [Abstract][Full Text] [Related]
6. Analytical detection and characterization of biopharmaceutical glycosylation by MS. Oh MJ; Hua S; Kim U; Kim HJ; Lee J; Kim JH; An HJ Bioanalysis; 2016 Apr; 8(7):711-27. PubMed ID: 26964748 [TBL] [Abstract][Full Text] [Related]
7. Comparability study of Rituximab originator and follow-on biopharmaceutical. Montacir O; Montacir H; Eravci M; Springer A; Hinderlich S; Saadati A; Parr MK J Pharm Biomed Anal; 2017 Jun; 140():239-251. PubMed ID: 28371718 [TBL] [Abstract][Full Text] [Related]
8. Glycosimilarity assessment of biotherapeutics 1: Quantitative comparison of the N-glycosylation of the innovator and a biosimilar version of etanercept. Borza B; Szigeti M; Szekrenyes A; Hajba L; Guttman A J Pharm Biomed Anal; 2018 May; 153():182-185. PubMed ID: 29499461 [TBL] [Abstract][Full Text] [Related]
9. On the glycosylation aspects of biosimilarity. Hajba L; Szekrényes Á; Borza B; Guttman A Drug Discov Today; 2018 Mar; 23(3):616-625. PubMed ID: 29337201 [TBL] [Abstract][Full Text] [Related]
10. Analytical tools for characterizing biopharmaceuticals and the implications for biosimilars. Berkowitz SA; Engen JR; Mazzeo JR; Jones GB Nat Rev Drug Discov; 2012 Jun; 11(7):527-40. PubMed ID: 22743980 [TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies biosimilarity assessment using transient isotachophoresis capillary zone electrophoresis-tandem mass spectrometry. Gahoual R; Biacchi M; Chicher J; Kuhn L; Hammann P; Beck A; Leize-Wagner E; François YN MAbs; 2014; 6(6):1464-73. PubMed ID: 25484058 [TBL] [Abstract][Full Text] [Related]
13. The criticality of high-resolution N-linked carbohydrate assays and detailed characterization of antibody effector function in the context of biosimilar development. Brady LJ; Velayudhan J; Visone DB; Daugherty KC; Bartron JL; Coon M; Cornwall C; Hinckley PJ; Connell-Crowley L MAbs; 2015; 7(3):562-70. PubMed ID: 25898160 [TBL] [Abstract][Full Text] [Related]
14. Trastuzumab and Pertuzumab Plant Biosimilars: Modification of Asn297-linked Glycan of the mAbs Produced in a Plant with Fucosyltransferase and Xylosyltransferase Gene Knockouts. Komarova TV; Sheshukova EV; Kosobokova EN; Serebryakova MV; Kosorukov VS; Tashlitsky VN; Dorokhov YL Biochemistry (Mosc); 2017 Apr; 82(4):510-520. PubMed ID: 28371609 [TBL] [Abstract][Full Text] [Related]
15. Protein glycosylation and its impact on biotechnology. Berger M; Kaup M; Blanchard V Adv Biochem Eng Biotechnol; 2012; 127():165-85. PubMed ID: 21975953 [TBL] [Abstract][Full Text] [Related]
16. Glycosylation Analysis of Therapeutic Glycoproteins Produced in CHO Cells. Carillo S; Mittermayr S; Farrell A; Albrecht S; Bones J Methods Mol Biol; 2017; 1603():227-241. PubMed ID: 28493134 [TBL] [Abstract][Full Text] [Related]
17. Mass spectrometry-based glycoprofiling of biopharmaceuticals by using an automated data processing tool: SimGlycan Puranik A; Goswami R; Sutar P; Tupe D; Rasam P; Dandekar P; Jain R J Sep Sci; 2023 Feb; 46(3):e2200521. PubMed ID: 36463509 [TBL] [Abstract][Full Text] [Related]
18. The Mechanistic Impact of N-Glycosylation on Stability, Pharmacokinetics, and Immunogenicity of Therapeutic Proteins. Zhou Q; Qiu H J Pharm Sci; 2019 Apr; 108(4):1366-1377. PubMed ID: 30471292 [TBL] [Abstract][Full Text] [Related]
19. Online nanoliquid chromatography-mass spectrometry and nanofluorescence detection for high-resolution quantitative N-glycan analysis. Kalay H; Ambrosini M; van Berkel PH; Parren PW; van Kooyk Y; García Vallejo JJ Anal Biochem; 2012 Apr; 423(1):153-62. PubMed ID: 22330744 [TBL] [Abstract][Full Text] [Related]
20. Analytical platform for glycomic characterization of recombinant erythropoietin biotherapeutics and biosimilars by MS. Oh MJ; Hua S; Kim BJ; Jeong HN; Jeong SH; Grimm R; Yoo JS; An HJ Bioanalysis; 2013 Mar; 5(5):545-59. PubMed ID: 23425271 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]